NCMI News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$193.8M

Volume

372.37K

Next Earnings

October 29th

Chart Financials Earnings News About Dividends Insider Filings

Stock Market Today, June 18: AMC Rallies After Record May Attendance Drives Trading MomentumAMC Entertainment rallied 6.39% on June 18, 2026, driven by record May attendance—the highest since 2019. The stock benefited from strong summer box-office momentum, though investors remain cautious about the company's $4 billion debt load and recent $150 million dilutive equity offering. Trading volume surged 140% above average as the broader market gained, with the S&P 500 up 1.08% and Nasdaq up 1.91%.The Motley Fool · Jun 18, 2026

Here's What Key Metrics Tell Us About National CineMedia (NCMI) Q2 EarningsNational CineMedia reported a 269.6% year-over-year increase in revenue for Q2 2024, beating analyst estimates. However, EPS of -$0.09 missed expectations. The company's advertising revenue metrics were mixed compared to analyst projections.Zacks Investment Research · Aug 5, 2024

National CineMedia (NCMI) Upgraded to Buy: What Does It Mean for the Stock?National CineMedia (NCMI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.Zacks Investment Research · May 29, 2024

Is National CineMedia (NCMI) Outperforming Other Business Services Stocks This Year?Here is how National CineMedia (NCMI) and FiscalNote Holdings, Inc. (NOTE) have performed compared to their sector so far this year.Zacks Investment Research · May 17, 2024

National CineMedia (NCMI) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesThe headline numbers for National CineMedia (NCMI) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.Zacks Investment Research · May 6, 2024

Zacks Industry Outlook Highlights Publicis Groupe, National CineMedia and AdTheorent HoldingPublicis Groupe, National CineMedia and AdTheorent Holding are part of the Zacks Industry Outlook article.Zacks Investment Research · Apr 9, 2024

3 Advertising & Marketing Stocks to Watch Amid Industry WoesThe Zacks Advertising and Marketing industry is expected to gradually reach the pre-pandemic healthy levels with an increase in service activities. PUBGY, NCMI and ADTH are likely to ride on the digital marketing surge and client-centric strategies.Zacks Investment Research · Apr 8, 2024

Top 3 Tech And Telecom Stocks That Are Ticking Portfolio BombsAs of March 21, 2024, three stocks in the communication services sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI ...Benzinga · Mar 21, 2024

Unveiling 4 Analyst Insights On National CineMediaRatings for National CineMedia (NASDAQ:NCMI) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 2 0 0 Last 30D 0 1 0 0 0 1M Ago 1 0 2 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $5.69, a high estimate of $6.75, and a low estimate of $4.50. This current average has increased by 26.44% from the previous average price target of $4.50. Diving into Analyst Ratings: An In-Depth Exploration The standing of National CineMedia among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Mike Hickey Benchmark Maintains Speculative Buy $6.00 - Michael Pachter Wedbush Raises Neutral $5.50 $4.50 Eric Wold B. Riley Securities Raises Buy $6.75 $4.50 Michael Pachter Wedbush Maintains Neutral $4.50 - Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to National CineMedia. This insight ...Full story available on Benzinga.comBenzinga · Mar 20, 2024

Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionShares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. Peraso posted a quarterly loss of $8.52 per share, versus analysts’ estimates for a loss of $3.76 per share. The company’s quarterly sales came in at $1.83 million versus expectations of $1.70 million. Peraso shares tumbled 23.3% to $1.32 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Ontrak, Inc. (NASDAQ: OTRK) shares climbed 197.8% to $0.5660 ahead of the company's presentation at the 36th Annual Roth Conference. Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) gained 97.3% to $20.99 after the company announced agreed to be acquired by AstraZeneca. Also, Leerink Partners downgraded the stock from Outperform to Market Perform but raised its price target from $17 to $21. SCWorx Corp. (NASDAQ: WORX) gained 74% to $3.22. Spire Global, Inc. (NYSE: SPIR) climbed 50.7% to $18.50 after announcing a collaboration with NVIDIA to advance AI-driven weather prediction. Enveric Biosciences, Inc (NASDAQ: ENVB) shares climbed 43.6% to $1.5801 after the company announced that it signed two non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of cannabinoid-COX-2 conjugate compounds for pharmaceutical and non-pharmaceutical applications for the treatment of joint diseases. Zoomcar Holdings, Inc. (NASDAQ: ZCAR) rose 33.1% to $1.57 after the company announced that it partnered with EaseMyTrip to integrate its cars within the travel platform. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 32% to $1.51 after the company announced pre-clinical research showcasing the potential of HT-ALZ in Alzheimer's disease. Enliven Therapeutics, Inc. (NASDAQ: ELVN) gained 27.2% to $16.09. The company announced a $90 million private placement financing and provided pipeline updates. National CineMedia, Inc. (NASDAQ: NCMI) gained 25.5% to $5.30 after the company posted upbeat results for its fourth quarter and disclosed a new $100 million share repurchase program. The company said it sees first-quarter total revenue of $34.5 million to $35.5 million. Alignment Healthcare, Inc. (NASDAQ: ALHC) gained 17.7% to $5.50. Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose 15% to $43.63 ...Benzinga · Mar 19, 2024

NCMINational CineMedia, Inc.

NCMI

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any NCMI yet.

Related Tickers

Earnings

Dividends

Last · May 22Quarterly

Amount$0.0300

Yield4.38%

Annual$0.0900

Mkt Cap

$194.2M

Volume

372.37K

Next Earnings

October 29th